Paramount's bond buyers are charging it for a deadline and a crowded junk market

By
CTOL Staff Reporter
1 min read

Paramount is selling $44 billion of bonds to fund its $110 billion takeover of Warner Bros Discovery. The second-lien notes are pricing near 9%, about 210 basis points above the 6.9% average for similarly rated debt, because the deal must close before October or Paramount owes WBD shareholders $7 million a day.

Paramount Skydance is raising $44 billion of bonds to fund its $110 billion takeover of Warner Bros Discovery, and investors are showing up for it. Second-lien junk notes have drawn more than $23 billion of orders against a tranche of roughly $12 billion, in what is set to be the largest high-yield bond sale on record, topping SoftBank's recent deal. First-lien investment-grade notes drew more than $51 billion of indications on a book of about $32 billion, enough to rank among the five largest such offerings ever sold. The order books show demand, not whether the bonds are fairly priced. The 10-year second-lien note is pricing near 9%, about 210 basis points above the 6.9% average for similarly rated bonds, and the five-year euro tranche of the same junk debt is pricing at 7.5%. Investors are charging that premium for the deadline.

If the takeover does not close before October, Paramount owes Warner Bros Discovery shareholders $7 million a day in ticking fees. WBD's shareholders approved the deal in April and the Department of Justice cleared it in June, but lawsuits from twelve state attorneys general and the Writers Guild dragged on for months before both sides settled last week. That left Paramount pricing $44 billion of debt, spread across eight tranches of first-lien notes maturing anywhere from two to forty years plus separate dollar and euro second-lien tranches, into a market where the 10-year Treasury yield has climbed 0.86 percentage points in three months to 5.24%, the highest since 2007. The Federal Reserve raised rates again on September 16 and meets next on October 27 and 28. The market was already moving against Paramount as the legal window narrowed. The financing was structured so Paramount, not its banks, absorbs that move, which means every week of delay in the courtroom showed up later as extra yield in the bond math.

The financing cost of the delay is substantial. A single percentage point of extra yield on $44 billion of debt runs to about $440 million a year in interest. The ticking fee, by comparison, costs about $210 million a month, so a single month's delay costs roughly half a year of that extra point. Paramount chose to pay up rather than wait, and the arithmetic says it had little choice. The interest expense will weigh on a company whose linear television cash flow keeps shrinking. The deal capped a months-long bidding contest with Netflix, which Paramount won, but the legal fights that delayed closing left it exposed to a Treasury market that moved firmly against it.

The ratings split helps explain the demand for the investment-grade notes. Fitch and S&P rate the first-lien notes BBB-minus, investment grade. Moody's rates the identical notes Ba1, one notch into junk territory, and rates the second-lien notes B1; Fitch puts the second lien at BB. All three agencies treat the second lien as junk. Most bond indices classify an issue by the middle of its three ratings, so the first-lien notes count as investment grade for index-tracking buyers even though a third of the rating opinion disagrees. This index treatment may explain why a $32 billion tranche attracted $51 billion of interest, despite mixed views of Paramount's credit. It also means the pricing gap between first-lien and second-lien debt understates how much of the deal the market treats as speculative.

Some investors will read the size of both order books as proof the credit is sound. Indications of interest can be trimmed or pulled before final pricing, so a crowded book mainly shows that buyers like being paid extra to show up. At 9% on ten-year second-lien paper, they are being compensated for the squeeze Paramount created by needing the deal closed before October. A full order book says buyers like the coupon; it says little about how they rate the merger itself. Pricing this rich all but guarantees the book clears, which is a different thing from a fair price.

The high-yield market is getting crowded as well. Goldman Sachs strategists said on Monday that a surge of US high-yield supply is starting to overwhelm investors, pushing junk risk premiums to their highest in five months, and Paramount's second-lien tranche is the biggest single slug of that supply. Paramount struck its agreement with Warner Bros Discovery in February, and the bond sale is the last major piece of a $52 billion package that also includes $7.5 billion of loans marketed last week, the largest M&A financing of 2026. Bloomberg reported that Paramount, working with banks including BofA and Citi, is aiming to price the final tranches this week. The size of the package means Paramount needs more debt than the market can absorb cheaply, especially with a fixed legal deadline. Its eight first-lien tranches, some due in forty years, spread the cost across a generation of future cash flow rather than concentrating it in the near term.

Books are expected to close and price near current talk by Wednesday, September 30. Once the takeover itself closes, expect Paramount's first public move to be asset sales or explicit deleveraging targets aimed at defending the investment-grade rating that only two of its three raters currently grant it. The desk expects the second-lien notes, priced richest relative to comparable debt, to be the first to trade below issue if the 10-year Treasury keeps climbing toward the Federal Reserve's October 27-28 meeting, and Friday's October 2 payrolls report is the nearer-term test of whether that climb continues.

You May Also Like

This article is submitted by our user under the News Submission Rules and Guidelines. The cover photo is computer generated art for illustrative purposes only; not indicative of factual content. If you believe this article infringes upon copyright rights, please do not hesitate to report it by sending an email to us. Your vigilance and cooperation are invaluable in helping us maintain a respectful and legally compliant community.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings

We use cookies on our website to enable certain functions, to provide more relevant information to you and to optimize your experience on our website. Further information can be found in our Privacy Policy and our Terms of Service . Mandatory information can be found in the legal notice